Global Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsight
The oncology-based in-vivo CRO market is witnessing robust growth, driven by the increasing global burden of cancer and the rising demand for preclinical oncology research. Pharmaceutical and biotechnology companies are increasingly outsourcing in-vivo studies to specialized CROs to…
News provided by PR Newswire.
